Advances in tumor immunology and immunotherapy / ed. J.D.Rosenblatt et al. - New York: Springer Science+Business Media, 2014. - ix, 371 p.: ill. - (Current cancer research). - Bibliogr. at the end of the art. - Ind.: p.365-371. - ISBN 978-1-4614-8808-8 Шифр: (И/Р56-A22) 02  Место хранения:   02 | Отделение ГПНТБ СО РАН | Новосибирск

Оглавление / Contents

Part I. Immune Activation, Suppression and Manipulation of the Immune Antitumor Response Myeloid-Derived Suppressor Cells in Cancer ...................... 3 Christos E. Kyriakopoulos, Alberto J. Monterao, and Claudia Marcela Diaz-Montero The Role of В Cells in Shaping the Antitumor Immune Response ... 19 Yu Zhang, Taylor H. Schreiber, and Joseph D. Rosenblatt Heat-Shock Protein-Based Cancer Immunotherapy .................. 37 Taylor H. Schreiber Activation of NK Cell Responses and Immunotherapy of Cancer .... 57 George J. Weiner Induction of Tumor Immunity by Targeted Inhibition of Nonsense-Mediated mRNA Decay ................................ 67 Eli Gilboa Employing T Cell Homeostasis as an Antitumor Strategy .......... 83 Shawn M. Jensen, Christopher C. Paustain, and Bernard A. Fox Adoptive Cell Therapy of Systemic Metastases Using erbB-2- Specific T Cells Redirected with a Chimeric Antibody-Based Receptor ...................................................... 107 Dinorah Friedmann-Morvinski, Tova Waks, Assaf Marcus, and Zelig Eshhar Part II. Evolving Clinical Immunotherapeutic Strategies Immunotherapy in Renal Cell Carcinoma ......................... 125 Jennifer Cudris and Jaime R. Merchan Adoptive T-Cell Transfer as a Clinical Antitumor Strategy for Hematologic Malignancies .................................. 149 Aaron P. Rapoport and Nadia Ijaz Bifunctional Antibodies: Preclinical and Clinical Applications .................................................. 183 Casey W. Shuptrine and Louis M. Weiner Clinical Development of Antibody-Fusion Proteins for Cancer Therapy ....................................................... 213 Kory L. Alderson, Amy K. Erbe, Margaret Boyden, and Paul M. Sondel Immunologic Outcomes of Allogeneic Stem Cell Transplantation: Graft-Versus-Host and Graft-Versus-Leukemia Responses and Implications for Future Therapy ........................... 237 Lazaros J. Lekakis and Krishna V. Komanduri The Immune System in Head and Neck Squamous Cell Carcinoma: Interactions and Therapeutic Opportunities .................... 275 Paolo Serafini and Donald T. Weed T Cell Co-regulatory Signals and Their Role in Cancer Therapy ....................................................... 323 Eitan R. Friedman, Lynn Feun, Pasquale Benedetto, and Joseph D. Rosenblatt Assessment of Immune Response in Biotherapy Trials and Clinical Endpoints ............................................ 343 Theresa L. Whiteside Index ......................................................... 365